Log in
NASDAQ:BEAT

BioTelemetry Stock Forecast, Price & News

$43.47
+1.32 (+3.13 %)
(As of 10/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$42.01
Now: $43.47
$43.66
50-Day Range
$35.95
MA: $42.74
$45.58
52-Week Range
$27.35
Now: $43.47
$55.85
Volume183,100 shs
Average Volume335,714 shs
Market Capitalization$1.49 billion
P/E Ratio83.60
Dividend YieldN/A
Beta1.14
BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core lab services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in Healthcare, Research, and Corporate and Other segments. The Healthcare segment focuses on the remote cardiac monitoring to identify arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, and non-loop event monitors. It also provides Holter and extended-wear Holter monitors, and INR monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The Corporate and Other segment focuses on the manufacture, engineering, development, and sale of non-invasive cardiac monitors and other population health management devices for healthcare companies, as well as contract manufacturing services under the BioTel Care and BioTel Alliance names. The company was founded in 1994 and is headquartered in Malvern, Pennsylvania.
Read More
BioTelemetry logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.65 out of 5 stars

Industry, Sector and Symbol

Industry Specialty outpatient clinics, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:BEAT
CUSIPN/A
Phone610-729-7000
Employees1,700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$439.11 million
Cash Flow$3.49 per share
Book Value$10.83 per share

Profitability

Net Income$29.84 million

Miscellaneous

Market Cap$1.49 billion
Next Earnings Date10/29/2020 (Confirmed)
OptionableOptionable
$43.47
+1.32 (+3.13 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BEAT News and Ratings via Email

Sign-up to receive the latest news and ratings for BEAT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











BioTelemetry (NASDAQ:BEAT) Frequently Asked Questions

How has BioTelemetry's stock price been impacted by Coronavirus (COVID-19)?

BioTelemetry's stock was trading at $37.55 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BEAT stock has increased by 15.8% and is now trading at $43.47.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of BioTelemetry?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BioTelemetry in the last year. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for BioTelemetry
.

When is BioTelemetry's next earnings date?

BioTelemetry is scheduled to release its next quarterly earnings announcement on Thursday, October 29th 2020.
View our earnings forecast for BioTelemetry
.

How can I listen to BioTelemetry's earnings call?

BioTelemetry will be holding an earnings conference call on Thursday, October 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were BioTelemetry's earnings last quarter?

BioTelemetry Inc (NASDAQ:BEAT) released its earnings results on Thursday, July, 30th. The medical research company reported $0.35 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.16 by $0.19. The medical research company earned $99.11 million during the quarter, compared to analyst estimates of $85.93 million. BioTelemetry had a net margin of 4.42% and a return on equity of 17.68%.
View BioTelemetry's earnings history
.

What price target have analysts set for BEAT?

6 analysts have issued 1-year target prices for BioTelemetry's shares. Their forecasts range from $43.00 to $80.00. On average, they anticipate BioTelemetry's share price to reach $60.50 in the next year. This suggests a possible upside of 39.2% from the stock's current price.
View analysts' price targets for BioTelemetry
.

Who are some of BioTelemetry's key competitors?

What other stocks do shareholders of BioTelemetry own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioTelemetry investors own include NVIDIA (NVDA), Micron Technology (MU), Advanced Micro Devices (AMD), Canopy Growth (CGC), Square (SQ), AT&T (T), AbbVie (ABBV), Alibaba Group (BABA), Netflix (NFLX) and Gilead Sciences (GILD).

Who are BioTelemetry's key executives?

BioTelemetry's management team includes the following people:
  • Mr. Joseph H. Capper, CEO, Pres & Director (Age 55)
  • Ms. Heather C. Getz, Exec. VP & CFO (Age 44)
  • Mr. Peter F. Ferola, Sr. VP, Gen. Counsel & Sec. (Age 50)
  • Mr. Fred Broadway III, Pres of BioTel Heart (Age 49)
  • Mr. Daniel M. Wisniewski, Sr. VP of Technical Operations (Age 55)

What is BioTelemetry's stock symbol?

BioTelemetry trades on the NASDAQ under the ticker symbol "BEAT."

Who are BioTelemetry's major shareholders?

BioTelemetry's stock is owned by a number of retail and institutional investors. Top institutional investors include Summit Creek Advisors LLC (1.27%), Scout Investments Inc. (0.51%), Cambiar Investors LLC (0.15%), Kirr Marbach & Co. LLC IN (0.11%), Foundry Partners LLC (0.08%) and Curbstone Financial Management Corp (0.07%). Company insiders that own BioTelemetry stock include Heather C Getz, Kirk E Gorman, Peter Ferola and Robert J Rubin.
View institutional ownership trends for BioTelemetry
.

Which major investors are selling BioTelemetry stock?

BEAT stock was sold by a variety of institutional investors in the last quarter, including Cadence Capital Management LLC, Envestnet Asset Management Inc., Scout Investments Inc., Kirr Marbach & Co. LLC IN, Resources Investment Advisors LLC., and Foundry Partners LLC.
View insider buying and selling activity for BioTelemetry
.

Which major investors are buying BioTelemetry stock?

BEAT stock was purchased by a variety of institutional investors in the last quarter, including Summit Creek Advisors LLC, Cambiar Investors LLC, Louisiana State Employees Retirement System, Nisa Investment Advisors LLC, Mesirow Financial Investment Management Inc., Curbstone Financial Management Corp, and Campbell Newman Asset Management Inc..
View insider buying and selling activity for BioTelemetry
.

How do I buy shares of BioTelemetry?

Shares of BEAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is BioTelemetry's stock price today?

One share of BEAT stock can currently be purchased for approximately $43.47.

How big of a company is BioTelemetry?

BioTelemetry has a market capitalization of $1.49 billion and generates $439.11 million in revenue each year. The medical research company earns $29.84 million in net income (profit) each year or $1.95 on an earnings per share basis. BioTelemetry employs 1,700 workers across the globe.

What is BioTelemetry's official website?

The official website for BioTelemetry is www.gobio.com.

How can I contact BioTelemetry?

BioTelemetry's mailing address is 1000 CEDAR HOLLOW ROAD, MALVERN PA, 19355. The medical research company can be reached via phone at 610-729-7000 or via email at [email protected]

This page was last updated on 10/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.